Explore more publications!

Puerto Rico Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.

Press releases published on February 10, 2026

BetterWorld Technology Appoints Yadira Galarza-Berrios, Esq., LL.M, PPM as General Counsel and Regional Director
Leadership Changes

Leadership Changes

Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Results
Kailera Therapeutics and Hengrui Pharma Report Positive Topline Data from Phase 2 Obesity Trial of Oral Ribupatide
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
Aeluma Names Bouchaib Nessar Senior Vice President of Business Development and Product
Aurora Mobile’s GPTBots.ai and Hong Kong Ants Asia Forge Strategic Partnership for AI Innovation
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Polyrizon Intends to Secure Controlling Stake in Profitable Private Jet Operator
Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting
Microchip Technology Announces Upsize and Pricing of Offering of $800 Million of Convertible Senior Notes
Ragnarok: Twilight Official Launching in Vietnam on February 10, 2026
Yatiri Bio Accurately Predicts AML Drug Response in Blinded Study Using Foghorn’s FHD-286
Realmo Democratizes Data Discovery with Next-Gen Search: Integrating Natural Language Processing for Complex CRE Queries
Viomi Technology Co., Ltd Announces Board Changes
Camp and Mugafi Close Fully-subscribed Onchain Vault to Finance Swari Agra, a Bollywood Historical Film Released February 6
True Tickets and Twickets Partner to Launch Face Value Ticket Resale for UK Venues
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions